Deirdre Baggot is a highly respected figure in the healthcare industry. She has shown an excellent reputation in her career that has earned her fame and honor. She is the woman behind the bundled payment system. She currently works as the vice president of the Camden Group in Los Angeles, California. She has gained global recognition due to the transformation that she has brought to the healthcare industry. Deirdre has an incredible academic background that is admired by many people throughout the world. She did her education at the University of Southern Illinois and earned a bachelor’s degree in Nursing. Afterward, she went for higher education at Loyola University and attained an MBA after which she pursued a Doctorate in philosophy. This is a great achievement because there are only a few who have such level of academic qualification. Learn more about Deirdre Baggot at Ideamensch
The fantastic career journey by Ms. Deirdre Baggot started in 1997, and since then, she has consistently built on her career. This serves as a great inspiration to many people especially women from the whole world. Deirdre Baggot started her career as a staff nurse, a resource coordinator and hospital administration in Northwest Memorial Hospital. She served in this institution for around six years and then moved to Ann Abor which is located in Michigan where she served as an administrative manager as well as a business analyst. She has made gradual success that has earned him great recognition in the entire healthcare department. She has made posted great result in all the institutions that she has worked with. Deirdre Baggot went to Denver in Colorado in 2006 and served as a senior administrator at the famous Cardiac and Vascular Institute. This institute is a branch of the Sisters of Charity of Leavenworth health. Ms. Baggot has made an everlasting legacy.
Jim Tananbaum is the chief executive and founder of Foresite Capital. Mr. Tananbaum founded Foresite Capital as a private equity firm that focusses solely in the healthcare industry. The firm identifies upcoming healthcare leaders and then provides them with capital, information and networks. Most companies who have received assistance from Foresite have achieved profitability.
Before founding Foresite Capital, Jim cofounded two healthcare investment firms and two prominent pharmaceutical companies. His first firm, GelTex, brought two drugs to the medical market at a cost of less than $80 million. The company was acquired in 1998 for $1.6 billion. At the time of the acquisition its leading drug Renagel was bringing in revenue in excess of $200 million. As of 2017 Renagel produces $1 billion in annual revenue. Mr. Jim Tananbaum was also a founder and CEO of Theravance, Inc. The company has respiratory franchise with GSK through the joint venture Innoviva. Innoviva has a market capitalization of $3.2 billion.
Early in his investment career Jim was a partner at Sierra Ventures where he assisted them in establishing their healthcare investment department. He was also a founder at Prospect Venture Partners 2 and 3. During his investment career Jim led numerous investments such as Amira Pharmaceuticals, which was acquired by Amerigroup, Jazz Pharmaceuticals and Healtheon. Jim used the wealth of knowledge and experience from his previous ventures to make a unique venture capital firm.
Jim Tananbaum attended college at Yale where he double majored in electrical engineering and computer science. He then obtained his MBA and MD from Harvard. He got his MS from MIT. Since a young age Jim has always been passionate about the marriage of computer science, mathematics and healthcare. During his studies he established productive and deep relationships with many leading academicians. He was also credits the following individuals for mentoring him Rick Levin (Yale), Valegos Roy (Merck and Theravence) and Whitesides George (Harvard). Jims experience has led him to believe that the world is about to enter a golden age where change and growth is driven by insights form data and deep learning. He envisions a future whereby blood and tissue from individuals is sequenced to prevent diseases before they even occur. You can visit his About.me page to know more about Jim.
See more: https://ideamensch.com/jim-tananbaum/